MTaI supports DTAB’s proposal for new vertical in CDSCO to check ‘garage…
The association states that creation of a separate vertical in Central Drugs Standard Control Organisation (CDSCO) exclusively to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck- FSSAI collaboration starts a Center for Microbiological Analysis Training (C-MAT)
Merck and FSSAI have started a microbiological testing laboratory to enhance skill development in food safety industry
Research conducted at IIT Mandi shows that zinc supplementation suppresses fat deposition in the…
In a research study done by scientists at IIT Mandi, it was found that zinc oxide nanoparticles can prevent fat accumulation in…
Takeda announces Andrey Potapov as ICMEA Area Head
Potapov, who was previously assigned as General Manager of Takeda's operations in Russia and Head of the CIS Area, has taken over…
Glenmark launches novel, globally-researched anti-diabetes drug Remogliflozin in India
Remogliflozin is an innovative, patent-protected sodium glucose co-transporter-2 (SGLT2) inhibitor indicated in treatment of…
Cipla receives final approval for generic version of Gilead Sciences’ Letairis
Cipla’s Ambrisentan Tablet, 5 mg and 10 mg, is an AB-rated generic therapeutic equivalent version of Gilead Sciences' Letairis
Decks cleared for expansion of Aurobindo Pharma’s plant in AP
Ministry of Environment, Forests and Climate Change has given clearance to Aurobindo Pharma's drugs and intermediates…
Gilead experimental NASH drug fails another study
California-based Gilead's experimental drug, selonsertib, aimed at treating the fatty liver disease failed to pass yet another…
GSK’s HIV drug wins European panel thumbs-up
The drug company has received approval from the European Medicines Agency (EMA) for its two-drug treatment for HIV infections…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
The FDA’s decision will allow the drug, developed by Regeneron along with Sanofi SA, to be prescribed to reduce the overall risk…